Long-term comparisons of citrate and heparin as anticoagulants for hemodialysis.
Citrate was compared to heparin as an anticoagulant during chronic hemodialysis. A randomized crossover design was used in six stable male dialysis patients. There were no measurable crossover effects. Use of citrate as the sole anticoagulant for periods of 2 months was easily accomplished, free of complications, and resulted in comparable clearance of solutes. Major laboratory parameters were similar with both anticoagulants. Importantly, there was no significant citrate accumulation. The results also indicate that recurrent use of heparin during dialysis has no measurable effect on lipid metabolism in stable patients.
D000925:Anticoagulants / Q000008:administration & dosage*; D002951:Citrates / Q000008:administration & dosage*; D019343:Citric Acid; D002986:Clinical Trials as Topic; D006493:Heparin / Q000008:administration & dosage*; D006801:Humans; D007260:Infusion Pumps; D007676:Kidney Failure, Chronic / Q000628:therapy; D008055:Lipids / Q000097:blood; D008134:Long-Term Care; D008297:Male; D008875:Middle Aged; D011897:Random Allocation; D006435:Renal Dialysis
D000925:Anticoagulants; D002951:Citrates; D008055:Lipids; D019343:Citric Acid; D006493:Heparin